FTC: MDS Must Sell Arcturus Business to Life Technologies to Proceed with Danaher Deal | GenomeWeb

NEW YORK (GenomeWeb News) – The US Federal Trade Commission today said that it has ordered MDS to sell its Arcturus laser microdissection business to Life Technologies as a condition of approving its deal to sell its MDS Analytical Technologies unit to Danaher.

The FTC said that the sale would "resolve FTC charges that Danaher's acquisition of MDS Analytical Technologies would harm competition in the North American market for laser microdissection devices." It noted that Danaher and MDS are two of only four North American suppliers of such devices.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.